Pixium Vision announces its consolidated financial
Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023 ...
Stay updated with breaking news from Prima System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023 ...
Pixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023 Paris, April 21, 2023 - 7.00 a.m. CET
03.04.2023 - Communication following the announcement of FDA Breakthrough Device Designation for the Prima System in Dry AMD Conversion of 160 ORNAN2022 by ESGO with intention to pursue controlled trading of sharesCost reduction measures implemented ... Seite 1
The FDA granted breakthrough device designation to the Prima System, an implant designed to partially restore vision in patients with atrophic dry age-related macular degeneration, Pixium Vision announced.
Pixium Vision announced today that it received FDA breakthrough device designation for its Prima System for partially restoring vision.